Ossifi Inc.
Records under this name other than patents Ossifi Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,877,196 | Methods of Altering Bone Growth by Administration of Sost or Wise Antagonist or Agonist Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,608,373 | Methods of Altering Bone Growth by Administration of Sost or Wise Antagonist or Agonist Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,807,681 | Methods of Altering Bone Growth by Administration of Sost or Wise Antagonist or Agonist Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,891,438 | Methods of Altering Bone Growth by Administration of Sost or Wise Antagonist or Agonist Formerly held In force · Low confidence | In force | Low confidence | |
| US 8,178,099 | Methods of Altering Bone Growth by Administration of Sost or Wise Antagonist or Agonist Formerly held In force · High confidence | In force | High confidence | |
| US 9,540,365 | Compounds for bone growth Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,501,457 | Compounds for bone growth Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,267,814 | Compounds for bone growth Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,198,292 | Vinpocetine and eburnamonine derivatives for promoting bone growth, treating renal damage and cancer, and devices thereof Lapsed on the fee record Ended Jun 12, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2020 | From the USPTO record |
| US 8,188,065 | Boldine compounds for promoting bone growth Lapsed on the fee record Ended May 29, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 29, 2020 | From the USPTO record |